REPORT ID 420

Global Weight Loss Drugs Sales Market Report 2017

Publish Date
01-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the global Weight Loss Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Weight Loss Drugs for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Weight Loss Drugs market competition by top manufacturers/players, with Weight Loss Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche
    GSK group
    Teva
    Sandoz(Novartis)
    STADA-VN J.V.Co., Ltd
    Hexal AG
    National Company For Pharmaceutical Industry
    Lunan Pharmaceutical Group Corporation
    Zein Pharmaceutical
    Hisun
    Taj Pharmaceuticals Ltd
    Kabir Life Sciences & Research
    Dm Pharma
    China Zhongshan Pharm
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Liauid
    Tablets
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Weight-reducing Aid
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Weight Loss Drugs Sales Market Report 2017
1 Weight Loss Drugs Market Overview
    1.1 Product Overview and Scope of Weight Loss Drugs
    1.2 Classification of Weight Loss Drugs by Product Category
        1.2.1 Global Weight Loss Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Weight Loss Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Liauid
        1.2.4 Tablets
    1.3 Global Weight Loss Drugs Market by Application/End Users
        1.3.1 Global Weight Loss Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Weight-reducing Aid
        1.3.3 Other
    1.4 Global Weight Loss Drugs Market by Region
        1.4.1 Global Weight Loss Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Weight Loss Drugs Status and Prospect (2012-2022)
        1.4.3 China Weight Loss Drugs Status and Prospect (2012-2022)
        1.4.4 Europe Weight Loss Drugs Status and Prospect (2012-2022)
        1.4.5 Japan Weight Loss Drugs Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Weight Loss Drugs Status and Prospect (2012-2022)
        1.4.7 India Weight Loss Drugs Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Weight Loss Drugs (2012-2022)
        1.5.1 Global Weight Loss Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Weight Loss Drugs Revenue and Growth Rate (2012-2022)

2 Global Weight Loss Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Weight Loss Drugs Market Competition by Players/Suppliers
        2.1.1 Global Weight Loss Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Weight Loss Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Weight Loss Drugs (Volume and Value) by Type
        2.2.1 Global Weight Loss Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Weight Loss Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Weight Loss Drugs (Volume and Value) by Region
        2.3.1 Global Weight Loss Drugs Sales and Market Share by Region (2012-2017)
        2.3.2 Global Weight Loss Drugs Revenue and Market Share by Region (2012-2017)
    2.4 Global Weight Loss Drugs (Volume) by Application

3 United States Weight Loss Drugs (Volume, Value and Sales Price)
    3.1 United States Weight Loss Drugs Sales and Value (2012-2017)
        3.1.1 United States Weight Loss Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Weight Loss Drugs Sales Price Trend (2012-2017)
    3.2 United States Weight Loss Drugs Sales Volume and Market Share by Players
    3.3 United States Weight Loss Drugs Sales Volume and Market Share by Type
    3.4 United States Weight Loss Drugs Sales Volume and Market Share by Application

4 China Weight Loss Drugs (Volume, Value and Sales Price)
    4.1 China Weight Loss Drugs Sales and Value (2012-2017)
        4.1.1 China Weight Loss Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Weight Loss Drugs Sales Price Trend (2012-2017)
    4.2 China Weight Loss Drugs Sales Volume and Market Share by Players
    4.3 China Weight Loss Drugs Sales Volume and Market Share by Type
    4.4 China Weight Loss Drugs Sales Volume and Market Share by Application

5 Europe Weight Loss Drugs (Volume, Value and Sales Price)
    5.1 Europe Weight Loss Drugs Sales and Value (2012-2017)
        5.1.1 Europe Weight Loss Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Weight Loss Drugs Sales Price Trend (2012-2017)
    5.2 Europe Weight Loss Drugs Sales Volume and Market Share by Players
    5.3 Europe Weight Loss Drugs Sales Volume and Market Share by Type
    5.4 Europe Weight Loss Drugs Sales Volume and Market Share by Application

6 Japan Weight Loss Drugs (Volume, Value and Sales Price)
    6.1 Japan Weight Loss Drugs Sales and Value (2012-2017)
        6.1.1 Japan Weight Loss Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Weight Loss Drugs Sales Price Trend (2012-2017)
    6.2 Japan Weight Loss Drugs Sales Volume and Market Share by Players
    6.3 Japan Weight Loss Drugs Sales Volume and Market Share by Type
    6.4 Japan Weight Loss Drugs Sales Volume and Market Share by Application

7 Southeast Asia Weight Loss Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Weight Loss Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Weight Loss Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Weight Loss Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Weight Loss Drugs Sales Volume and Market Share by Players
    7.3 Southeast Asia Weight Loss Drugs Sales Volume and Market Share by Type
    7.4 Southeast Asia Weight Loss Drugs Sales Volume and Market Share by Application

8 India Weight Loss Drugs (Volume, Value and Sales Price)
    8.1 India Weight Loss Drugs Sales and Value (2012-2017)
        8.1.1 India Weight Loss Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Weight Loss Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Weight Loss Drugs Sales Price Trend (2012-2017)
    8.2 India Weight Loss Drugs Sales Volume and Market Share by Players
    8.3 India Weight Loss Drugs Sales Volume and Market Share by Type
    8.4 India Weight Loss Drugs Sales Volume and Market Share by Application

9 Global Weight Loss Drugs Players/Suppliers Profiles and Sales Data
    9.1 Roche
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Weight Loss Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Roche Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 GSK group
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Weight Loss Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 GSK group Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Teva
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Weight Loss Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Teva Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Sandoz(Novartis)
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Weight Loss Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Sandoz(Novartis) Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 STADA-VN J.V.Co., Ltd
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Weight Loss Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Hexal AG
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Weight Loss Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Hexal AG Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 National Company For Pharmaceutical Industry
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Weight Loss Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Lunan Pharmaceutical Group Corporation
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Weight Loss Drugs Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Zein Pharmaceutical
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Weight Loss Drugs Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Zein Pharmaceutical Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Hisun
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Weight Loss Drugs Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Hisun Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Taj Pharmaceuticals Ltd
    9.12 Kabir Life Sciences & Research
    9.13 Dm Pharma
    9.14 China Zhongshan Pharm

10 Weight Loss Drugs Maufacturing Cost Analysis
    10.1 Weight Loss Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Weight Loss Drugs
    10.3 Manufacturing Process Analysis of Weight Loss Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Weight Loss Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Weight Loss Drugs Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Weight Loss Drugs Market Forecast (2017-2022)
    14.1 Global Weight Loss Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Weight Loss Drugs Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Weight Loss Drugs Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Weight Loss Drugs Price and Trend Forecast (2017-2022)
    14.2 Global Weight Loss Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Weight Loss Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Weight Loss Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Weight Loss Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Weight Loss Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Weight Loss Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Weight Loss Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Weight Loss Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Weight Loss Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Weight Loss Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Weight Loss Drugs Sales Forecast by Type (2017-2022)
       14.3.2 Global Weight Loss Drugs Revenue Forecast by Type (2017-2022)
       14.3.3 Global Weight Loss Drugs Price Forecast by Type (2017-2022)
    14.4 Global Weight Loss Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer